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Conclusion: Increased UA level was independent predictor of increased
morbidity and mortality in a cohort of ambulatory patients with chronic heart
failure.
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Backround: Hyponatremia – lowering of sodium in blood serum below
135 mmol/l – is a frequent disorder of electrolyte metabolism in patients with
chronic heart failure (CHF). It is an established predictor of adverse outcomes
in hospitalized patients with reduced ejection fraction.
Aim: To evaluate the incidence of hyponatremia in ambulatory patients
diagnosed with chronic heart failure in order to establish a correlation with the
risk factors, evolution and prognosis.
Methods and Results: We examined the prevalence, risk factors, and
long-term outcomes of hyponatremia (serum sodium =< 135 mEq/L) in ambu-
latory HF with reduced EF The cohort consisted of 1240 admitted in the ther-
apeutic unit of heart failure (TUHF) between 2006 and 2014. Hyponatremia
was present in 19.6 %. Mean serum levels of natremia and were 131.3 meq/l.
Hyponatremia was associated with male sex, diabetes, strock attack, coronary
heart disease. Compared with normonatremic patients, those with hypona-
tremia had lower systolic blood pressure and lower functional capacity during
six – minute walk. Also, Hyponatremia was associated with cardiac decom-
pensation, diastolic dysfunction (p=0.014), severe renal insufficiency and
higher doses of diuretics (p<0.0001), whereas beta-blockers were inversely
associated (P<0.0001).
Conclusion: Patients with heart failure and hyponatraemia on showed a
higher risk of long-term morbidity than patients without.
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Heart failure is a clinical syndrome resulting from impaired function of the
myocardium. This study sought to describe and compare specific characteris-
tics, baseline clinical profile and intrahospital mortality of patients admitted in
intensive care unit (ICU) for acute myocardial infarction with sustained ST-
segment elevation (STEMI) according to their left ventricle ejection fraction
(LVEF).
Methods: We included 79 patients over first quarter 2013. Patients with
LVEF < 40% constituted group1 (n=22; 27.8%) and were compared to
patients’ group2, n=57; 72.2% with LVEF ≥40%. 
For each patient, cardiovascular history, maximum Killip class, period
chest pain, heart rate (HR), troponine level, kidney function and CRP were
recorded.
Results: The average age was 59.6 years. Patients’ group1 were older:
64.4 years against 57.8 years for patients’ group2. Sex ratio did not differ with
a male predominance 68% in both groups.
Patients’ group1 were more frequently hypertensive (50% vs. 36.84%) and
had history of coronary heredity in 9% of cases vs. 1.75% in group2. They
presented in a shorter chest pain time (5.4 hours vs. 6.7 hours) and were more
frequentely tachycardiac (HR≥100 bpm): 40.9% vs. 17.5% in group2. Patients
in group 1 had significantly more congestive heart failure (22.72% of patients
were ≥ killip II vs. 1.75% in group2) (p = 0.006). Troponines were positive in
95% in both groups with an average of 47.01 ng/ml in group1 vs 42.38 ng/ml
in group2. Group1 presented lower mean Glomerular Filtration Rate (GFR):
58,2ml/min vs 87,16mL/min and higher CRP (average 93.11mg/l vs 50.28mg/l
in group2). The short term Survival was higher in group2 (94.74% vs
86.37%). 
Conclusion: Our study shows that older age, tachycardia, CHF, prior
hypertensive, and higher CRP were more associated with moderate to severe
impaired LVEF at admission in patients with STEMI. We think taht a rapid
assessment of LVEF in the IUC will identify a population at risk who needs
sharper hospital care.
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The aim of the study was to analyze the epidemiologic, clinical and etio-
logic aspects of heart failure of the young age to 18 to 45 years.
It consisted of an observational study realized in the day hospital unit
(DHU) in the service of cardiology of the University Hospital Ibn Rochd of
Casablanca during 60 months (January 2009 to December 2013) comparing
young patients (to 18 to 45 years) to older. The completion of a Doppler echo-
cardiography was necessary to include the patients in the study.
Results: The median age of the patients was of 37.12 ± 3 years with a sex
ratio of 2/3.2 vs. 69.7 years and a sex ratio of 2/3.1. Young subjects were less
frequently hypertensive, diabetic and dyslipidemic (p<0.001). The electrocar-
diogram found only 16.9% in complete arrhythmia by auricular fibrillation in
younger vs. 11.3% in patients more than 45 years. Cardiac echography found
a dilation of the left ventricle among 47.9% vs. 42.7%, a systolic dysfunction
of left ventricle among 35% vs. 66.2%. We noted that heart failure with pre-
served ejection fraction (HFPEF) was predominant in this population
(p<0.001). The etiologies were: hypertension 31.8% vs. 1.6% (p <0.001),
heart valve diseases 17.1% vs. 10.3% (p =0.003), the peripartum cardiomyop-
athy 6.9% vs. 0.1% (p <0.0001), dilated cardiomyopathy 14.1 % vs. 8.4
(p=0.0023), the alcoholism 2.8% vs. 1.2% (p =0.22), ischemic heart diseases
22.2% vs. 60.1% (p <0.001), arhythmia 2.8% vs. 0.3% (p <0.001), the cardio-
thyreosis 2.8% vs. 1.1% (p=0.19) and myocarditis 1.4% vs. 0.9% (p <0.001).
Young subjects were poorly compliant with beta-blockers and Aldactone
because of their side effects.
Conclusion: Heart failure is a serious and frequent pathology in North
Africa. It affects young and active subjects too with a predominance of
HFPEF. Causes are dominated by hypertension.
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Background: Sleep disordered breathing (SDB) is common in patients
with heart failure with reduced ejection fraction (HFrEF). Increased apnoea-
hypopnoea index (AHI) is predictive of poor outcome. Nocturnal desaturation
(ND) is associated with increase in NT-proBNP in HFrEF. The prognostic
value of ND as compared to AHI is still unknown.
Methods and Results: Three-hundred seventy six consecutive patients
with stable chronic HFrEF and left ventricular ejection fraction (LVEF)
≤45% were prospectively screened for SDB between 2005 and 2010 by
polygraphy. SDB was defined by an AHI≥5 and sleep apnea (SA) by an
AHI≥15. Mean age was 59±13 years, mean LVEF 30%±6%, and mean AHI
18±10; 310 patients (82%) had SDB. The predefined composite primary
end-point (death, heart transplantation or left ventricular assistance)
occurred in 98 patients (26%) within 3 years. Minimal oxygen saturation
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(MOS) during sleep, number of desaturations <90%/hour and time spent
with oxygen saturation <90% were significantly associated with adverse
events (HR 1.25, 1.25, and 1.28 respectively) after adjustment for
confounders, whereas AHI was not. Best MOS cut-off value for poor out-
come was ≤88%. Patients with MOS ≤88% without SA had similar event
rates than those with MOS ≤88% with SA. Patients with MOS ≤88% had a
significantly higher event rate than those with MOS >88% (p<0.01). Risk
assessment using MOS of ≤88% in addition to established prognostic
markers of HFrEF yielded a net reclassification index (NRI) of nearby 6%,
and was particularly useful in the subgroup of patients with events (NRI
8,4%).
Conclusions: In HFrEF, nocturnal desaturation ≤88% is a stronger pre-
dictor of adverse events than AHI, independently of the presence of SA. This
suggests that risk assessment in HFrEF should include MOS, and that SDB
treatment may also focus on patients without SA presenting nocturnal desatu-
ration.
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